Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : ¾Ë¸²¸¶´ç : ¿¬±¸¼Ò ´º½º
   
¾Ë¸²¸¶´ç
°øÁö»çÇ×
º¸µµÀÚ·á
ÀÎÀçä¿ë
 
 
Á¦   ¸ñ [´ëÇѾà»çÀú³Î]È£ÁÖ ¹ãÀ» ¹àÈ÷´Â 'Supercare' ¾à±¹
³»   ¿ë
Âü¿© ¿¬±¸¿ø ÀÓÀ翵 ½ÇÀå/±èÁøÀ̠åÀÓ¿¬±¸¿ø/Á¤µ¿¿í ºÎ¼±ÀÓ¿¬±¸¿ø
ÆíÁý ÀÌÁÖÇÏ ÁÖÀÓ¿¬±¸¿ø


<Áö³­È£¿¡ À̾>
1. ±¹³»¿Ü ÇöȲ ¹× »ç·ÊÁ¶»ç
(2) ±¹¿Ü
1) È£ÁÖ
ºòÅ丮¾Æ Á¤ºÎ´Â 2018³â±îÁö 20°³ÀÇ Supercare ¾à±¹ ¿î¿µÀ» À§ÇØ 2870¸¸ ´Þ·¯¸¦ ÅõÀÔÇß´Ù. ÀÌ ºñ¿ë ¿Ü È«º¸¸¦ À§ÇÑ Ä·ÆäÀΠºñ¿ëÀ¸·Î »ç¾÷ ÀÌÈÄ 3³â¿¡ °ÉÃÄ ºòÅ丮¾ÆÁÖ ÁÖ Á¤ºÎ´Â ÀÌ »õ·Î¿î Á¦µµ¿¡ ´ëÇÑ »ç¶÷µéÀÇ ÀνÄÀ» ³ôÀ̱â À§ÇØ »ç¾÷ 1Â÷ ¿¬µµÀΠ2017³â 7¿ù 1ÀϺÎÅÍ 2018³â 6¿ù 30ÀϱîÁö 1³â°£ 36¸¸5000´Þ·¯¸¦ »ç¿ëÇß´Ù.

±× ÈÄ 2, 3Â÷ ¿¬µµ¿¡µµ Supercare ¾à±¹À» À§ÇØ 26¸¸7544´Þ·¯¸¦ Ä·ÆäÀΠºñ¿ëÀ¸·Î »ç¿ëÇßÀ¸¸ç, 2019³â¿¡´Â ¾à µÎ´Þ °£ 129.35´Þ·¯¸¦ Ä·ÆäÀΠºñ¿ëÀ¸·Î »ç¿ëÇß´Ù<Ç¥1 ÂüÁ¶>.


Supercare ¾à±¹Àº °æÀïÀÔÂû °úÁ¤À» °ÅÃÄ ¼±Á¤µÈ´Ù. Áö¿ª Àǻ糪 ´Ù¸¥ ÀÇ·á ¼­ºñ½º°¡ °¡´ÉÇÏÁö ¾ÊÀº ½É¾ß½Ã°£¿¡ ¸¹Àº »ç¶÷µéÀÌ ÀǾàǰ°ú °Ç°­ »ó´ãÀÌ ÇÊ¿äÇÏ´Ù. ¾à±¹Àº Áö¿ª»çȸ¿¡¼­ À̿͠ÀǾàǰ Á¦°ø ¹× »ó´ã°ú °ü·ÃÇØ ½Å·Ú¹Þ´Â ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ½É¾ß½Ã°£¿¡ ¼­ºñ½º¸¦ Á¦°øÇϱâ À§ÇØ ÀûÁ¤È÷ ¹èÄ¡µÅ ÀÖ´Ù.

Supercare ¾à±¹Àº ºòÅ丮¾Æ ÁÖ Àü¿ª¿¡¼­ 24½Ã°£ ¾à±¹ÀÌ ¿î¿µµÇ´Â Á¤ºÎ Áö¿ø ÇÁ·Î±×·¥À¸·Î ½É¾ß½Ã°£ÀÇ ¾à¹°¿¡ ´ëÇÑ ´ë¸é »ó´ã, °æ¹ÌÇÑ ºÎ»ó Ä¡·á¸¦ Çϸç ÀǾàǰÀ» Á¦°øÇÑ´Ù. È¯ÀÚµéÀº ¾à¹° »ó´ã, ÀǾàǰ °ø±Þ ¹× Ã³¹æ¾à Á¶Á¦¸¦ À§ÇØ ¾à»ç¸¦ 24½Ã°£ ¸¸³¯ ¼ö ÀÖ´Ù.

ºòÅ丮¾Æ Á¤ºÎ´Â ¾à±¹À» ¼±Á¤Çϴ ÀýÂ÷¸¦ ¹â¾Æ ¼öµµ ¹× Áö¿ª ºòÅ丮¾Æ Àü¿ª¿¡ °ÉÃÄ Àα¸ ¹× ¼­ºñ½º ¿ä±¸¿¡ µû¶ó ¾à±¹À» Áö¸®ÀûÀ¸·Î ÀûÀýÇϰԠºÐ¹èÇØ ¼­ºñ½º°¡ Á¦°øµÉ ¼ö ÀÖµµ·Ï ÇßÀ¸¸ç, Supercare ¾à±¹Àº Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µ ¹× Æò°¡µÉ ¿¹Á¤ÀÌ´Ù. È£ÁÖ º¸°Çº¹ÁöºÎ(Department of Health and Human Services)´Â ¼­ºñ½º Á¦°ø ¾÷ü ¹× ÁÖ¿ä ÀÌÇØ °ü°èÀÚ¿Í Çù·ÂÇØ Supercare ¾à±¹ÀÌ ÀÀ±Þ °ü·Ã ¼­ºñ½º ¸ñÇ¥¸¦ Áö¼ÓÀûÀ¸·Î ÃæÁ·Çϵµ·Ï Çϰí ÀÖ´Ù.

Supercare ¾à±¹Àº ÁÖ 7ÀÏ, 24½Ã°£ °³¿øÇϵµ·Ï Á¤ºÎ°¡ Áö¿øÇϸ砿ܰüÀº ´Ù¸¥ ¾à±¹°ú ºñ½ÁÇÏÁö¸¸ Supercare Pharmacy ¼­ºñ½º¸¦ Á¦°øÇѴٴ ǥ½Ã°¡ ÀÖ´Ù.

Á¤ºÎ°¡ ¾à±¹ÀÌ ´õ ¸¹Àº ½Ã°£À» ¿­µµ·Ï ÀÚ±ÝÀ» Áö¿øÇϴ ÀÌÀ¯´Â ¸¹Àº »ç¶÷µéÀÇ °æ¿ì ÇöÁö Àǻ砶Ǵ ±âŸ ÀÇ·á ¼­ºñ½º¸¦ ÀÌ¿ëÇÒ ¼ö ¾ø´Â ±Ù¹« ½Ã°£ ÀÌÈÄ¿¡ ÀǾàǰ ¹× °Ç°­ »ó´ãÀ» ¹Þ¾Æ¾ßÇϴµ¥, ¾à±¹Àº À̹̠Ŀ¹Â´ÏƼ ³»¿¡¼­ ½Å·ÚÇÒ ¼ö Àִ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç ÀÌ ¼­ºñ½º¸¦ Á¦°øÇÒ ¼ö Àִ À§Ä¡¿¡ ÀÖ´Ù. 

°¢ ¾à±¹¿¡´Â ¾ß°£¿¡ °æºñ¿øÀÌ ÀÖÀ¸¸ç »óȲ¿¡ µû¶ó ÀûÀýÇÑ ÀÀ±Þ ¼­ºñ½º°¡ Á¦°øµÈ´Ù.

Supercare ¾à±¹ À§Ä¡¸¦ ¼±ÅÃÇϱâ À§Çؼ­ º¸°Çº¹ÁöºÎ(Department of Health and Human Services)´Â °æÀï·Â Àִ ÀÔÂû ÇÁ·Î¼¼½º¸¦ »ç¿ëÇØ °¢ ÀáÀçÀû À§Ä¡°¡ Àα¸ ¿ä±¸¸¦ ÃæÁ·½Ã۴ ¹æ¹ý¿¡ ´ëÇÑ Æò°¡¸¦ Æ÷ÇÔÇØ ±âÁ¸ ¼­ºñ½º¿Í ÅëÇÕÇÏ°í °Ç°­°ü¸®, ¿¹¹æ ¹× È«º¸¸¦ Áö¿øÇÒ ¼ö Àִ ¹æ¹ýÀ» Æò°¡ÇØ ¾à±¹À» ¼±Á¤Çß´Ù. <´ÙÀ½È£¿¡ °è¼Ó>

 

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
129 [´ëÇѾà»çÀú³Î]°ø°ø½É¾ß¾à±¹, »ç¾÷ È®´ë À§ÇØ ¿î¿µ¡¤ÆíÀÇ °³¼± ÇÊ¿ä ÀÌÁÖÇÏ 2021-09-23 1150
128 [´ëÇѾà»çÀú³Î]½É¾ß½Ã°£ ¾à±¹ ÀÌ¿ë '¸¸Á·ÇÑ´Ù' 93.5% ÀÌÁÖÇÏ 2021-09-23 1027
127 [´ëÇѾà»çÀú³Î]¿µ±¹, OHH ¼­ºñ½º ÀϹݾࡤÀü¹®¾à ³ª´² Á¦°ø ÀÌÁÖÇÏ 2021-09-23 986
126 [´ëÇѾà»çÀú³Î]È£ÁÖ ¹ãÀ» ¹àÈ÷´Â 'Supercare' ¾à±¹ ÀÌÁÖÇÏ 2021-09-23 1007
125 [ÀǾàǰÁ¤Ã¥¸®Æ÷Æ®]ÀÀ´äÀÚ 94.3% µµÀÔ Âù¼º¡¦Àü¹®Àû »ó´ã Àý½Ç ÀÌÁÖÇÏ 2021-09-23 320
124 [´ëÇѾà»çÀú³Î] ¾à ±¸ÀÔ ½Ã ¾à»ç¿Í »ó´ãÀÌ Áß¿ä 85% ÀÌÁö¿¬ 2021-08-10 609
123 [´ëÇѾà»çÀú³Î] ÀǾàǰ ¾ÈÀü»ç¿ë ±³À° 'µµ¿òµÆ´Ù' 98% ÀÌÁö¿¬ 2021-08-02 535
122 [´ëÇѾà»çÀú³Î] ¾ÆÆí ÇÔÀ¯ 'Á¤ÅëÆí' ÅëÁõ ¸¸º´ÅëÄ¡¾àó·³ »ç¿ë ÀÌÁö¿¬ 2021-08-02 581
121 [´ëÇѾà»çÀú³Î] ºÏÇÑÀÌÅ»ÁֹΠó¹æÀǾàǰ È¿°ú ½Å·Ú ´õ ³ô¾Æ ÀÌÁö¿¬ 2021-07-21 536
120 [´ëÇѾà»çÀú³Î] ºÏÇÑÀÌÅ»ÁֹΠÀǾàǰ Àνİú »ç¿ë ÇöȲÀº? ÀÌÁö¿¬ 2021-07-14 475
119 [´ëÇѾà»çÀú³Î] "ºÎÀÛ¿ë °æÇè 98% Áõ»ó ½Å°í¾ÈÇØ" ºÒ°¨Áõ ½É°¢ ÀÌÁö¿¬ 2021-07-07 547
118 [´ëÇѾà»çÀú³Î] ¾ÈÀü»óºñÀǾàǰ ±¸ÀÔ ¿äÀÏ ÁÖ¸» '50.3%' Â÷Áö ÀÌÁö¿¬ 2021-06-29 530
117 [´ëÇѾà»çÀú³Î] ±¹¹Î 90% 1³â°£ ÆíÀÇÁ¡ »óºñ¾à ÃÖ´ë 5ȸ ±¸ÀÔ ÀÌÁö¿¬ 2021-06-22 567
116 [´ëÇѾà»çÀú³Î] ÆíÀÇÁ¡ ºøÀå Ç®¸®ÀÚ ½ñ¾ÆÁø °¨±â¾à¡¤ÁøÅëÁ¦ ÀÌÁö¿¬ 2021-06-16 511
115 [´ëÇѾà»çÀú³Î] Áö¿ª¾à±¹ '»ý¸íÁöÅ´ÀÌ' ¿ªÇÒ ¼öÇà °ü½É ³ôÇû´Ù ÀÌÁö¿¬ 2021-06-09 518

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  ´ÙÀ½ 10ÆäÀÌÁö

 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»